Informa Australia is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Register Your Interest

Comments

Bio Connections Australia

Translation | Commercialising Great Science | Partnering for Growth

25 July 2022 | Collins Square Event Centre, Melbourne

Book Now Register Your Interest Download Brochure

overview

Returning for 2022, Bio Connections Australia will take place on the 25th July 2022 at Collins Square Event Centre, Melbourne.

For 2022, we look forward to bringing together a diverse mix of biotechnology companies, pharmaceutical companies, medical technology companies, VCs and other investors, MRIs, CROs, trial sites, universities and clinical trial networks.

Bio Connections Australia 2022 has an important focus for 2022 on translation, drug development and expediting Australia’s great science into commercialization.

Ongoing work is needed to drive Australia to become globally competitive in novel therapeutics and create better pathways for companies to translate their great research into commercial products.

speakers

Grant Dooley

CEO, Breakthrough Victoria

Dr Anand Gautam

Executive Director & Emerging Science Lead, Emerging Science & Innovation, Asia & APAC (Australia & New Zealand), Pfizer R&D

A/Prof Simon Wilkins

Head of Operations - CUREator, MRCF, Brandon Capital Partners

Michael Molinari

MD Australia, IP Group

Dr Phil Kearney

CEO, Axelia Oncology

Larisa Chisholm

COO, Denteric Pty Ltd

Dr Stuart Newman

CEO, Therapeutic Innovation Australia

Professor Doug Hilton

Director, WEHI

Dr Nicole van der Weerden

COO, Hexima Ltd

Andrew Mitchell

General Manager Healthcare, Linfox

Dr Catherine Drinkwater

Director of Project Management, BioCurate

Professor Craig Rayner

Distinguished Scientist, Certara

Prof. Jonathan Baell

Director, Australian Translational Research Facility (ATMCF), and Professor of Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences

Erik Wolf

Vice President, Conafay Group

Paul McDonald

Head of Quality and Development, IDT

Dr. Tina Soulis

Founder & Director, Alithia Life Sciences Pty Ltd

Georgina Kilfoil

VP Clinical Operations Asia Pacific, atai Life Sciences

Liz Ferentinos

Director, ESFAM Biotech Pty Ltd

Dr Emma Ball

Head of Illumina for Startups Australia, Illumina

Dr Andrew Nash

Chief Scientific Officer & Senior Vice President Research, CSL

Sarah Meibusch

Principal, OneVentures

Associate Professor Tam C. Nguyen

Deputy Director Research, St Vincent’s Hospital Melbourne

Dr Caroline Herd

CEO, QID Pharma

Dr Marthe D’Ombrain

Senior Director and Head of Global Research Innovation, CSL

Carolyn Shrives

Assistant Secretary, University Research Commercialisation Branch, Australian Government Department of Education

Dr Gareth Lewis

Chief Commercial Officer, Certa Therapeutics

A/Prof Susan Evans

CEO & Founder, Alyra Biotech

agenda

8:30 am

This session will be live streamed in the conference room. Erik will be available for live virtual Q&A later in the morning

9:00 am

Opening remarks from the Chair

Associate Professor Tam C. Nguyen, Deputy Director Research, St Vincent’s Hospital Melbourne

9:10 am

KEYNOTE ADDRESS | Investing for impact: How Breakthrough Victoria will invest in Australian innovation

Grant Dooley, CEO, Breakthrough Victoria

9:35 am

KEYNOTE ADDRESS | Accelerating translation of Australia’s medical research

Dr Andrew Nash, Chief Scientific Officer & Senior Vice President Research, CSL

10:00 am

  • How do investors see the next 5-10 years?
  • Trends in technologies and modalities – what’s on the horizon?
  • What are investors looking for in investee companies?
  • How can we drive more collaboration between investment community and big pharma to drive better outcomes? Can pharma advise on substrate they are investing in?
  • How can companies position themselves for capital success?
  • What sort of companies are investors looking for? What should companies NOT do?

10:45 am

Networking Break + Live Q&A with Eric Wolf on Non-Dilutive Funding in the US

11:20 am

  • R&D – current challenges of moving innovation/candidates forward
  • VC/Pharma – what do they look for in assets and what motivates them to license? What are they looking for in a partner?
  • What are Australia’s capabilities in closing the bench to bed gap
    • How biotechs can ensure asset fits with what partners are looking for
    • Finding your hook – establishing superiority to what is currently avilable or the standard of care
    • What is your indication worth?
    • Key messages and tips e.g. how to ensure more commercialization potential for your asset

12:45 pm

Networking Lunch

1:45 pm

  • How do we get patients through the door?
  • Considering the whole process of patient recruitment from finding patients, to contacting etc
  • Recruitment in healthy volunteers
  • Ensuring diversity – understanding the FDA guidance and why it’s important
  • Telehealth and teletrials – who are they suited to and the impact on recruitment
  • Decentralised clinical trials – does it create more opportunities, accelerate recruitment and save costs?
  • Machine learning to de risk and predictive analysis to apply targeted recruitment/retention plans
  • Ensuring predictability

2:30 pm

  • Understanding the perils of getting it wrong and what it takes to get it right
  • Understanding the global view on translation and the challenges
  • The different translation models, how we measure and execute:
    • University to industry translation
    • Industry knowledge translating through to university – encouraging greater agility
    • Industry to industry translation
  • What does the recent Australian Government University Research Commercialisation Action Plan and the BTF mean for universities and industry? What impact will it have?
  • What are the opportunities for biotechs and industry here?
  • How is translation giving rise to non-traditional companies being more engaged in the sector? What are the opportunities for partnering on strategy?

3:15 pm

Networking Break

3:45 pm

KEYNOTE | Leveraging Australian creativity in the supply chain to drive change in the patient experience

Andrew Mitchell, General Manager Healthcare, Linfox

4:10 pm

  • Changes in pharma transport and logistics – the impact of the pandemic
  • Cost of transport
  • Predictive modelling around the cost of cold chain
  • The impacts on pricing strategy

4:40 pm

  • To CEO or not to CEO?
  • Putting together a clinical or scientific advisory board – where do you start
  • Acquisition – how do you make that decision?
  • Raising equity
  • Regulation and reimbursement
  • Making the leap into global markets – where to start and how to get it right
  • Top 5 things which went wrong and learnings to share

5:20 pm

Closing remarks from Chair

5:30 pm

Networking Drinks

7:00 pm

BioPalooza Networking Dinner

sponsors

exhibitors

Partners

pricing

Packages Price
Standard 1 Day Pass$1695+GST
Extras Price
Dinner Ticket $150+GST
Packages Price
Standard 1 Day Pass$195+GST
Extras Price
Dinner Ticket $150+GST

The Biotech rate is only available to biotech companies. Please contact info@informa.com.au to enquire about the rate and eligibility.

CRO Breakfast Briefing

BREAKFAST BRIEFINGS AND MEETINGS | SELECTING THE RIGHT CRO
Monday 25th July 2022 | Pre-conference Roundtables
8am-9am

This session will include a series of short briefings followed by roundtables hosted by a range of different CROs. Take the opportunity to clarify what you’re looking for and how you can find the right CRO to fit your needs.

  • Where do you start?
  • Establishing suitability for your needs
  • What do they do, what should I pay them? Who’s right for me?
  • How can I get recommendations from the right people?
  • How do we ensure we provide the right scope for CRO partners?
  • What are the top ten things the biotech needs to provide to a CRO before they can start working together?
  • How Biotechs can arm themselves for doing business with CROs and making educated decision

Moderator: Dr. Tina Soulis, Founder & Director, Alithia Life Sciences Pty Ltd
Catherine Osborne, CEO, Crux Biolabs
Babaji Yadav, Senior Toxicology Consultant, Novotech

BIOPALOOZA IS BACK FOR 2022

We are delighted to announce the event networking dinner will be returning for the 2022 edition of Bio Connections Australia. Don’t miss out on this intimate get together and key networking opportunity to further discuss and connect following the conference with your fellow delegates and speakers in this informal setting.

Register Your Interest

Sponsorship & Exhibition Opportunities

Reconnect and re-engage with your industry peers at the Annual Bio Connections Australia Conference.

There are many opportunities for networking including social events such as the annual Bio Palooza Networking Dinner, networking drinks, refreshment breaks and lunches, making this not just a conference… but an all encompassing industry “experience”.

Event sponsorship or exhibiting will allow your organisation to:

  • Build relationships with potential and existing clients
  • Generate leads from a high-level, targeted audience
  • Close sales in a more personal manner than via phone
  • Demonstrate your product in person
  • Network with the industry
  • Build brand awareness

To see what is on offer please contact:

Danielle Newman
Senior Business Development Manager
E: danielle.newman@informa.com
T: +61 (2) 9080 4318

Sustainability

Our Commitment to Sustainability

In Australia, we are committed to running our events in an environmentally and socially responsible way. Across Informa Connect we are focusing on the short and long-term sustainability impacts we have on customers and colleagues alongside the communities we work in.

We recognise that it’s not just about the way we produce our events and products but recognising that we have a role to play in providing a space to work in partnership together with our markets to inspire the sustainable development of the industries we serve.

To read more on our latest sustainability reports and Faster Forward initiatives – click here.

when & where

25 Jul 2022

Collins Square Events Centre
Level 5, Tower 2/727 Collins St
Docklands VIC 3008
+61(03) 9252 7670

contact

Still have a question?

General Information & Registration
Customer Service
+61 (0) 2 9080 4307
info@informa.com.au

Sponsorship & Exhibition Opportunities
Danielle Newman
+61 (2) 9080 4318
Danielle.Newman@informa.com

Speaking Enquiries
Frankie Brewer
+61 2 9080 4319
francesca.brewer@informa.com

Marketing & Media Enquiries
Hannah Hori
+61 2 9080 4373
hannah.hori@informa.com

Get all the latest on Informa news and events

Informa Connect Australia is the nation's leading event organiser. Our events comprise of large scale exhibitions, industry conferences and highly specialised corporate training.

Find out more